Education ▼

SPECIALTY TOPICS

CURRENTLY VIEWING
Gynecologic Oncology

Breast Cancer

Multiple Myeloma

Lung Cancer

Immuno-Oncology News

Gastrointestinal Cancer

Colorectal Cancer

Ovarian Cancer

Prostate Cancer

Precision Medicine in Oncology^®

Neoadjuvant HER2+

More >>

Gynecologic Oncology

NICE Recommends Olaparib Maintenance in Relapsed, Platinum-Sensitive Ovarian Cancer

The National Institute for Health and Care Excellence has recommended the use of olaparib as a maintenance treatment in adults with relapsed, platinum-sensitive, high-grade epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Read More >>

PARP Inhibitors Gain Importance in Ovarian Cancer Lineup

FDA Grants Priority Review to Olaparib Plus Bevacizumab as Frontline Maintenance in Ovarian Cancer

Success Breeds a Need for Oncology Trials That Tackle Real-World Questions

The Dividing Line for Germline Mutation Testing Is Often Arbitrary

More Research Must Focus on Later-Line Therapies in Ovarian Cancer

View More Stories >>

View Conference Coverage

2019 San Antonio Breast Cancer Symposium

2019 ASH Annual Meeting

2019 International Congress of the Society for Melanoma Research

2019 State of the Science Summit on Genitourinary Cancers in Nashville

2019 State of the Science Summit on Hematologic Malignancies in Chicago

Dr. Schlumbrecht on Treatment in Uterine Leiomyosarcoma

Dr. Schlumbrecht on Remaining Challenges in Uterine Leiomyosarcoma

Dr. Hays on Immunotherapy in Ovarian Cancer Treatment

Dr. Schlumbrecht on the Role of Surgical Resection in Uterine Leiomyosarcoma

Dr. Berger on Frontline Treatment Options in Newly Diagnosed Advanced Ovarian Cancer

OncLive houses thousands of videos that provide updates and information.
See more Videos

The Future of Managing Gynecologic Cancer

Standard Frontline Therapy for Endometrial Cancer

Updates in Testing Endometrial Cancer Biomarkers

Frontline Therapies for Metastatic Cervical Cancer

Cervical Cancer: Staging and Minimally Invasive Surgery

OncLive houses thousands of videos that provide updates and information.
See more Videos

Future Directions in Advanced Ovarian Cancer Management

Genetic Counseling for Patients With Ovarian Cancer

Sequencing Antiangiogenic Agents in Advanced Ovarian Cancer

Sequencing PARP Inhibitors in Advanced Ovarian Cancer

Prepping Patients With Advanced OC for PARP Inhibition

Management of PARP Inhibitor AEs in Ovarian Cancer

Impact of SOLO-1 on Advanced Ovarian Cancer Management

OncLive houses thousands of videos that provide updates and information.
See more Videos

Featured Programs

Emerging Concepts-Advanced Ovarian, Fallopian, Peritoneal, and Cervical Cancers

This discussion, led by James Tate Thigpen, MD, features the most recent information pertaining to treatment of gynecologic malignancies. The expert panel, Robert L. Coleman, MD, FACOG, FACS; Thomas Herzog, MD; Bradley J. Monk, MD, FACOG, FACS; and Angeles Alvarez Secord, MD, review the research and how to apply it in practice.View Now

Challenges for the Future of Gynecologic Cancers

Panelists provide their perspectives on the key challenges facing the future of ovarian and cervical cancer treatment.View Now

Featured Video

Dr. Esteva on the Future of Biosimilars in Breast Cancer

Francisco J. Esteva, MD, PhD, director, breast medical oncology program, Laura and Isaac Perlmutter Cancer Center, NYU Langone Health, discusses the future use of biosimilars in breast cancer within the United States. View now

FDA Approvals in Urothelial Cancer and GIST, Promising Data in Urothelial Carcinoma, and More